ELOXX PHARMACEUTICALS, INC. Debt Securities
ELOXX PHARMACEUTICALS, INC. (ELOX) had Debt Securities of $9.50 million as of 2025-09-25, per its S-1 filed 2026-09-11.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecurities · last filed 2026-09-11
- 2025-09-25: Debt Securities $9.50M.
| Period end | Debt Securities |
|---|---|
| 2025-09-25 | $9.50M S-1 · filed 2026-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |